Spruce Biosciences Net Profit Margin Growth & History (SPRB)
Spruce Biosciences's net profit margin was −1,079.94% for fiscal 2024.
View full Spruce Biosciences company overviewSpruce Biosciences annual net profit margin history
| Fiscal year | Period ended | Net profit margin | Change (percentage points) |
|---|---|---|---|
| 2024 | 2024-12-31 | −1,079.94% | −604.98 pp |
| 2023 | 2023-12-31 | −474.96% | — |
Spruce Biosciences quarterly net profit margin
| Fiscal quarter | Period ended | Net profit margin | Change (percentage points) |
|---|---|---|---|
| Q4 2024 | 2024-12-31 | −3,380.06% | −3035.41 pp |
| Q3 2024 | 2024-09-30 | −1,440.37% | −1038.35 pp |
| Q2 2024 | 2024-06-30 | −570.25% | +22.08 pp |
| Q1 2024 | 2024-03-31 | −580.67% | +70.60 pp |
| Q4 2023 | 2023-12-31 | −344.65% | — |
| Q3 2023 | 2023-09-30 | −402.02% | — |
| Q2 2023 | 2023-06-30 | −592.33% | — |
| Q1 2023 | 2023-03-31 | −651.27% | — |
Spruce Biosciences net profit margin trends
Between the periods ended 2023-12-31 and 2024-12-31, Spruce Biosciences's net profit margin decreased from −474.96% to −1,079.94%, a change of −604.98 percentage points. The latest reported quarter, Q4 2024, shows −3,380.06%.
What net profit margin means
Net profit margin measures the percentage of revenue remaining as net income after operating costs, interest, taxes, and other expenses. It shows how much bottom-line profit or loss a company generates from each dollar of revenue.
How net profit margin is calculated
TickerStat calculates net profit margin as SEC-reported net income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Spruce Biosciences source filings ↗